[Therapy with antithrombin III concentrate].
Vinazzer
H
H
D000925:Anticoagulants / Q000627:therapeutic use; D000990:Antithrombin III / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D020152:Antithrombin III Deficiency; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000188:drug therapy; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006501:Hepatic Encephalopathy / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D010865:Pilot Projects; D012771:Shock, Hemorrhagic / Q000150:complications / Q000188:drug therapy; D012772:Shock, Septic / Q000150:complications / Q000188:drug therapy; D013923:Thromboembolism / Q000188:drug therapy* / Q000209:etiology
D000925:Anticoagulants; D000990:Antithrombin III
Terapia con i concentrati di antitrombina III.